Table 1.
Some clinical and lifestyle features of wet age-related macular degeneration patients and controls enrolled in this study.
| Feature | Control (n = 161) | Wet AMD (n = 225) | p 3 |
|---|---|---|---|
| Age (years) | 74.1 ± 6.3 | 78.4 ± 6.9 | 0.000 |
| Sex (male/female) | 52/109 | 70/155 | 0.368 |
| BMI (mean) | 25.7 ± 4.5 1 | 26.2 ± 4.1 2 | 0.161 |
| Smoking | 0.001 | ||
| Non-smoker | 93 (57.8%) | 140 (62.2%) | |
| Occasionally | 16 (9.9%) | 26 (11.6%) | |
| Smoker | 6 (3.7%) | 27 (12.0%) | |
| No information | 46 (28.6%) | 32 (14.2%) | |
| Medication | |||
| Blood pressure | 115 (79.3%) 1 | 164 (76.3%) 2 | 0.340 |
| Anti-cholesterol | 77 (53.1%) 1 | 93 (43.5%) 2 | 0.011 |
| Anticoagulant | 43 (29.5%) 1 | 64 (30.2%) 2 | 0.832 |
| Antiplatelet | 66 (44.6%) 1 | 109 (50.9%) 2 | 0.094 |
1n = 115 (BMI, body mass index), 145 (blood pressure), 145 (anti-cholesterol), 146 (anticoagulant), and 148 (antiplatelet); 2 n = 186 (BMI), 215 (blood pressure), 214 (anti-cholesterol), 212 (anticoagulant), and 214 (antiplatelet) 3 values of p < 0.05 are in bold mean ± SD for age and BMI.